AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18511533
Drug: Comprehensive pragmatic
RxNorm normalized name: chloroxylenol / pramoxine hydrochloride Otic Solution [Pramotic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive pragmatic manual therapy programme including specific corticosteroid injections (n = 89)
Trial: 10674267
Drug: Post-treatment follow-up
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment follow-up after 3 months
Trial: 22791944
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (G)
Trial: 31281061
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (fluticasone furoate-umeclidinium-vilanterol)
Trial: 31281061
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (fluticasone furoate-vilanterol)
Trial: 28757912
Drug: Protective lung
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective lung ventilation (6 mL/kg tidal volume and 10 cm H2O PEEP)
Trial: 9207389
Drug: 20 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/kg oxamniquine
Trial: 21176950
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg praziquantel
Trial: 2692093
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol
Trial: 22624993
Drug: Antioxidant cream
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant cream
Trial: 24945268
Drug: Barrier cream
RxNorm normalized name: Ceramax Skin Barrier Cream
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Barrier cream
Trial: 27378550
Drug: Amisulpride (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (400 mg)
Trial: 20530013
Drug: Pramipexole dihydrochloride
RxNorm normalized name: Pramipexole Dihydrochloride
DrugBank: Pramipexole (DB00413)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pramipexole dihydrochloride (0.5 mg)
Trial: 16841679
Drug: Neiyi pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neiyi pill (NP)
Trial: 16841679
Drug: Neiyi pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neiyi pill (NP) and Neiyi enema (NE)
Trial: 14520726
Drug: Dornase alfa
RxNorm normalized name: Dornase Alfa
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alfa (Pulmozyme) treatment
Trial: 3855724
Drug: Methyldopa (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (3.5 mg/kg) with sodium sulfate (13.25 mg/kg)
Trial: 3855724
Drug: Methyldopa (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (3.5 mg/kg) alone
Trial: 29737100
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg tenofovir disoproxil fumarate tablets under high-fat diet conditions
Trial: 22341736
Drug: SYNERGY half
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SYNERGY half dose
Trial: 16338260
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 mg daily for 8 weeks
Trial: 2756307
Drug: Iodine solution
RxNorm normalized name: Iodine solution
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine solution (2%)
Trial: 2756307
Drug: Barium suspension
RxNorm normalized name: barium
DrugBank: Barium (DB12481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barium suspension (1.5%)
Trial: 22565655
Drug: Exercise programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise programme aimed at improving handgrip (HS) and pinch strengths (PS) as well as motor coordination of the hand, 20 sessions, twice a week, at-home exercises
Trial: 22565655
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for hands (control)
Trial: 15589004
Drug: Trandolapril 4
RxNorm normalized name: trandolapril 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 4 mg/day
Trial: 2988589
Drug: Enalapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 40 mg/day
Trial: 9399748
Drug: High-dose histamine-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose histamine-2 receptor antagonist (H2RA) strategy
Trial: 9399748
Drug: Standard-dose histamine-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose histamine-2 receptor antagonist (H2RA) strategy
Trial: 1287614
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF 375 mg twice daily
Trial: 2992839
Drug: Minocromil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocromil (4 mg)
Trial: 30833367
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (CBT) plus lifestyle counseling
Trial: 29231587
Drug: Bobath therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bobath therapy
Trial: 23263355
Drug: idebenone (Catena;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: idebenone (Catena; 900 mg/d)
Trial: 17070426
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II receptor antagonist therapy in control group
Trial: 12668364
Drug: Ziprasidone (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone (40-80 mg twice daily)
Trial: 10743446
Drug: Ketamine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (bolus 0.1 mg kg‐1 over 10 min followed by infusion of 7 micrograms kg‐1 min‐1)
Trial: 10743446
Drug: Lidocaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (5 mg kg‐1)
Trial: 22528506
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution (50 mg)
Trial: 22403324
Drug: Pyronaridine/Artesunate (PA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyronaridine/Artesunate (PA) with Ritonavir (100 mg twice daily for 17 days, PA administered on Days 8-10)
Trial: 20353110
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: Routine treatments in western medicine including gastrointestinal decompression, parenteral nutrition, anti-infection, supportive therapy.
Trial: 20353110
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: Electroacupuncture in Zusanli (ST 36), Shangjuxu (ST 37) in addition to Group A treatments.
Trial: 10738013
Drug: MDI-S (metered-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI-S (metered-dose inhaler with spacer)
Trial: 28283823
Drug: Freeze-dried blueberry
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried blueberry (24 g/day, equivalent to 1 cup of fresh blueberries) for 90 days
Trial: 24793893
Drug: Topical tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical tranexamic acid (TXA) 3 g
Trial: 22817667
Drug: Erlotinib followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib followed by chemotherapy after progression
Trial: 22817667
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by erlotinib after progression
Trial: 11895146
Drug: TPN with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPN with fish oil (0.2 g/kg body weight per day) plus soybean oil (1.0 g/kg per day)
Trial: 11895146
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil (1.2 g/kg per day)
Trial: 9751068
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg salbutamol via metered-dose inhalers (MDIs)
Trial: 27152103
Drug: Acute oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute oral administration of 250 mL of mangosteen-based juice (305 mg of α-mangostin and 278 mg of hydroxycitric acid)
Trial: 21619670
Drug: Glucose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (50 g)
Trial: 12932433
Drug: Placebo (27.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (27.3 mg saccharin)
Trial: 9097873
Drug: m‐CPP (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m‐CPP (0.5 mg/kg of body weight)
Trial: 8040669
Drug: High-dose IL-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IL-2 (720,000 IU/kg)
Trial: 28807019
Drug: Antenatal syphilis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal syphilis screening and treatment intervention (details on dosage and duration not available)
Trial: 2675669
Drug: Propylene glycol
RxNorm normalized name: Propylene Glycol
DrugBank: Propylene glycol (DB01839)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propylene glycol formulation of etomidate (Hypnomidate)
Trial: 1253812
Drug: Fructose administered
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose administered simultaneously with ethanol
Trial: 1253812
Drug: Glucose administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose administered simultaneously with ethanol
Trial: 1253812
Drug: Glucose administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose administered 12 hours later during the hangover period
Trial: 17881390
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate (GA) treatment
Trial: 17111195
Drug: Thrombolysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis with ultra-high dose streptokinase (n = 8)
Trial: 15461606
Drug: Parietaria pollen
RxNorm normalized name: Parietaria officinalis extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parietaria pollen vaccine
Trial: 15317270
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo injections
Trial: 10668686
Drug: Unopposed conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unopposed conjugated equine estrogens (1.25 mg/day) for 16 weeks
Trial: 9061102
Drug: Oxycodone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (20 mg or 40 mg oral controlled-release tablet)
Trial: 3021324
Drug: Sulpiride (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (600 mg intramuscularly in a single administration, followed by 200 mg 3 times per day from days 2-21, then 100 mg and 50 mg 3 times per day on days 22-25 and 26-29, respectively)
Trial: 20188175
Drug: M01ZH09 (typhoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M01ZH09 (typhoid vaccine)
Trial: 6357036
Drug: Topical povidone‐iodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical povidone‐iodine spray in addition to a single dose of intravenous metronidazole
Trial: 6357036
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of intravenous metronidazole
Trial: 25902655
Drug: Perindopril 5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 5‐10 mg/day + Indapamide retard 1.5 mg/day (P+I)
Trial: 25902655
Drug: Perindopril 5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 5‐10 mg/day + Hydrochlorothiazide 25 mg/day (P+HT)
Trial: 15510982
Drug: rHuEPO (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO (5000 U/day subcutaneously three times a week) until three weeks after chemotherapy completion in Groups 1, 2A, and 3A
Trial: 16916538
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg cocaine
Trial: 3605793
Drug: epinephrine by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epinephrine by subcutaneous injection
Trial: 15975493
Drug: Control plus
RxNorm normalized name: SODIUM FLUORIDE 2.4 mg in 1 g DENTAL GEL, DENTIFRICE [AIM TARTAR CONTROL Plus Mouthwash and Whitening]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control plus 1000 mg of S. oblonga extract (S)
Trial: 11834946
Drug: ARV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARV therapy (ritonavir)
Trial: 11834946
Drug: ARV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARV therapy (zidovudine)
Trial: 11834946
Drug: ARV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARV therapy
Trial: 1519784
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl 50 micrograms.h‐1
Trial: 7747844
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl 75 micrograms.h‐1
Trial: 11764012
Drug: 0.125 mg
RxNorm normalized name: digoxin 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg triazolam
Trial: 22276954
Drug: Oral methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methadone
Trial: 28793993
Drug: Heparin 100
RxNorm normalized name: heparin 100 units/mL injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 100 IE/mL
Trial: 28793993
Drug: Taurolidine-citrate-heparin lock
RxNorm normalized name: heparin / taurolidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurolidine-citrate-heparin lock
Trial: 25749825
Drug: Intrathecal liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal liposomal cytarabine (50 mg)
Trial: 25749825
Drug: Intrathecal triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal triple therapy
Trial: 23406078
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg intravenous hydromorphone
Trial: 16083782
Drug: 250 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 microg of oral roflumilast
Trial: 16083782
Drug: 500 microg
RxNorm normalized name: Etizolam 500 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 microg of oral roflumilast
Trial: 17656354
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia with morphine
Trial: 6752250
Drug: Psychotherapy (weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy (weekly 30-50 minutes sessions of interpersonal psychotherapy)
Trial: 6752250
Drug: Pharmacotherapy (random
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (random assignment to either alprazolam, imipramine, or pill-placebo for six weeks)
Trial: 6752250
Drug: Community publicity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community publicity regarding psychotherapy treatment program
Trial: 20418510
Drug: Eltrombopag 100
RxNorm normalized name: eltrombopag 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 100 mg once daily
Trial: 20418510
Drug: Eltrombopag 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 150 mg once daily
Trial: 20418510
Drug: Eltrombopag 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 200 mg once daily
Trial: 20418510
Drug: Eltrombopag (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (all doses)
Trial: 7722161
Drug: Physician-targeted educational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician-targeted educational program on inhaled therapy (45 minutes, one-on-two teaching sessions)
Trial: 25162603
Drug: Oxycodone solution
RxNorm normalized name: oxycodone Injectable Solution
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone solution
Trial: 17645249
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment at Ganshu (BL 18), Shenshu (BL 23), Xinshu (BL 15), once daily.
Trial: 17645249
Drug: Fluoxetine hydrochloride,
RxNorm normalized name: FLUoxetine Hydrochloride, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine hydrochloride, 20 mg, once daily (control group).
Trial: 24807604
Drug: CO2-releasing suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2-releasing suppository
Trial: 7643191
Drug: 2.5 percent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 percent Lidocaine ointment
Trial: 2696231
Drug: Cefazolin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (4 X 0.5 g intravenously)
Trial: 29353709
Drug: Telenursing services
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenursing services (N=48) - weekly contact via telephone to motivate self-monitoring and healthy lifestyle.
Trial: 19890370
Drug: Amlodipine/benazepril (5/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/benazepril (5/20 or 10/40 mg daily)
Trial: 19890370
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 or 10 mg daily)
Trial: 15776333
Drug: Immediate pre-exercise,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate pre-exercise, orally ingested sodium load (164 mEq Na+) (IPOSL), equivalent to 10 ml per kilogram of body weight.
Trial: 15776333
Drug: Placebo beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage (Pl), hypotonic (94 mOsm . kg (‐1)), no-sodium, equivalent to 10 ml . kg (‐1) body weight.
Trial: 10333375
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of surgery and radiotherapy
Trial: 2016227
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose methylphenidate (0.4 mg/kg)
Trial: 29412045
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive use for more than 1 year
Trial: 18408362
Drug: Deferasirox (5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferasirox (5-30 mg/kg/day)
Trial: 31332099
Drug: Weekly regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly regimen (paclitaxel 90 mg/m2 on days 1, 8, and 15 with carboplatin AUC 6 on day 1 of every 4 weeks)
Trial: 31332099
Drug: Biweekly regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biweekly regimen (paclitaxel 135 mg/m2 with carboplatin AUC 3 on days 1 and 15 of every 4 weeks)
Trial: 29634142
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with alpha-blockers
Trial: 29634142
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 5-alpha reductase inhibitors and alpha-blockers
Trial: 29634142
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination drug Duodart
Trial: 28797281
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation (TENS) applied to the affected leg for 45 minutes daily, 5 days a week for 3 weeks at a frequency of 10 Hz and pulse width of 200 μs.
Trial: 23835365
Drug: Polaprezinc (PLZ)
RxNorm normalized name: polaprezinc
DrugBank: Polaprezinc (DB09221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polaprezinc (PLZ) 150 mg/d (116 mg CAR and 34 mg zinc)
Trial: 23835365
Drug: L-carnosine (CAR)
RxNorm normalized name: L-Carnosine
DrugBank: Carnosine (DB11695)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnosine (CAR) 116 mg/d
Trial: 17023720
Drug: Micronutrient supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplementation (250 mg vitamin C, 100 IU vitamin E, 37.5 mg selenium)
Trial: 17023720
Drug: Garlic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic supplementation (200 mg aged garlic extract and 1 mg steam-distilled garlic oil, twice daily)
Trial: 17023720
Drug: Short-term amoxicillin
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term amoxicillin (1 g) and omeprazole (20 mg) treatment
Trial: 10745279
Drug: Yoghurt fermented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoghurt fermented with one strain of Enterococcus faecium and two strains of Streptococcus thermophilus (CAUSIDO(R) culture), GAIO(R) (G)
Trial: 26304905
Drug: Placebo pills
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pills (PP)
Trial: 26551263
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of velpatasvir plus ribavirin